We caught up with Professor James Chalmers (University of Dundee, Dundee, Scotland, UK) to discuss the recent phase 2, WILLOW clinical trial (NCT03218917), its results and what the future holds for bresocatib in the treatment of non-cystic fibrosis bronchiectasis.
- Could you please give us a brief overview of non-cystic fibrosis bronchiectasis, its prevalence and the unmet needs in its treatment? (0:08)
- Could you tell us a little about brensocatib and its mechanism of action? (1:08)
- What were the aims and design of the WILLOW clinical trial? (2:06)
- What were the major efficacy and safety findings of the study? (2:50)
- What will be the next step in the clinical development of brensocatib? (4:19)
Speakers Disclosure: Prof. James Chalmers has received research grants from GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Pfizer, Grifols, Bayer AG, Polyphor and Insmed; and received consultancy, congress travel or speaker fees from GlaxoSmithKline, Bayer Healthcare, Aradigm Corporation, Grifols, Pfizer, Boehringer Ingelheim, Napp and Insmed.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress Congress 2020.
Share this Video
Related Videos In Bronchiectasis
Stefano Aliberti: What to Expect from the 3rd European Bronchiectasis Workshop
touchRESPIRATORY caught up with World Bronchiectasis & NTM Conference organising committee member, Prof. Stefano Aliberti (Humanitas University, Milan and IRCCS Humanitas Research Hospital, Lombardia, Italy) to learn more around the upcoming conference taking place in Milan in 2023 and about Prof. Aliberti’s bid to become the European Respiratory Society Vice President. The 5th World Bronchiectasis […]
Stefano Aliberti: Take Home Messages and the Patient Voice at the World Bronchiectasis & NTM Conference
It was a pleasure to talk with World Bronchiectasis & NTM Conference organising committee member, Prof. Stefano Aliberti (Humanitas University, Milan and IRCCS Humanitas Research Hospital, Lombardia, Italy) to discuss the experience of meeting in person at this year’s conference, the key take home messages of the roundtable on approaches to bronchiectasis and the importance […]
Francesco Blasi: Highlights from the World Bronchiectasis & NTM Conference
touchRESPIRATORY were delighted to catch up with World Bronchiectasis & NTM Conference organising committee member, Prof. Francesco Blasi (University of Milan and IRCCS Fondazione Cà Granda Ospedale Maggiore, Milan, Italy) to discuss the take home messages from this year’s conference, the importance of young researchers in the Bronchiectasis & NTM community and what to look forward […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!